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To rapidly assess possible community transmission 
in Noord-Brabant, the Netherlands, healthcare work-
ers (HCW) with mild respiratory complaints and with-
out epidemiological link (contact with confirmed case 
or visited areas with active circulation) were tested 
for severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2). Within 2 days, 1,097 HCW in nine hospi-
tals were tested; 45 (4.1%) were positive. Of six hospi-
tals with positive HCW, two accounted for 38 positive 
HCW. The results informed local and national risk 
management.
On 27 February 2020, the first case of coronavirus dis-
ease (COVID-19) was diagnosed in the Netherlands [1]. 
By 6 March, the number of cases had increased to 128 
[2]. Most of these cases had a travel history to north-
ern Italy or had been in close (household) contact with 
a laboratory-confirmed case. For 15 of the 128 cases 
the source of infection had not been determined. For 
seven of the 35 cases in the province of Noord-Brabant, 
the source of infection could not be established. Some 
cases elsewhere in the Netherlands were also linked 
to Noord-Brabant. Furthermore, in hospital B in Breda, 
which has offered low-threshold testing for employ-
ees with respiratory complaints since 2 March 2020, 
several healthcare workers (HCW) had tested positive 
for severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2). On Friday 6 March, the Dutch National 
Outbreak Management Team (OMT) convened to dis-
cuss the situation of coronavirus disease (COVID-19) 
in the Netherlands. The OMT decided that an urgent 
assessment of possible community transmission in the 
province of Noord-Brabant was needed.
Sampling of healthcare workers for 
SARS-CoV-2
The OMT decided to approach the assessment of possi-
ble community transmission in Noord-Brabant through 
sampling of HCW in hospitals in the province. A focus 
on HCW would simplify sampling, at such short notice, 
of adequate numbers of people with mild respiratory 
symptoms (coughing and/or sore throat and/or com-
mon cold) and without a known epidemiological link for 
SARS-CoV-2 exposure (travel to high-risk areas, close 
contact with confirmed case). Furthermore, knowledge 
of the status of SARS-CoV-2 infection among HCW 
would provide important insights for the participating 
hospitals regarding the infection status of staff and 
would inform hospital policies on testing algorithms for 
their personnel and on infection prevention measures.
Seven hospitals in the province of Noord-Brabant were 
approached in the afternoon of Friday 6 March and the 
morning of Saturday 7 March 2020 with the request 
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to test HCW through Sunday 8 March. Two hospitals 
indicated that they had already started systematic 
sampling of HCW as part of their hospital policy. Four 
hospitals had no systematic sampling policy for HCW 
but were testing all patients that presented at the 
emergency ward with respiratory complaints. In addi-
tion, two hospitals just outside Noord-Brabant with a 
large proportion of staff residing in the affected prov-
ince participated in the assessment (Figure). The par-
ticipating hospitals were asked to offer screening to 
HCW and share the results of the testing by 14:00 on 
Monday 9 March 2020. Upper respiratory tract speci-
mens (throat and/or nasopharyngeal swab) were col-
lected from HCW with mild respiratory complaints 
and without epidemiological link. Testing followed a 
uniform national protocol based on Corman et al. [3], 
that was rolled out by two central laboratories in the 
Netherlands. The testing was done either locally or in 
one of these two central laboratories.
Ethical approval was not required for this study as only 
anonymous aggregated data were used, and no medical 
interventions were made on human subjects. Sampling 
of HCW or patients was part of hospital policy.
In the period 6–8 March 2020, a total of 1,097 HCW 
(range per hospital: 11–294) in nine hospitals were 
tested for SARS-CoV-2, of whom 45 (4.1%) were found 
positive (Figure). Six hospitals had positive HCW of 
which two (hospital B and C) accounted for 38 of the 
45 positive HCW. The percentage of positive HCW per 
hospital varied between 0% and 9.5% with the highest 
percentages in hospital B in Breda (4.2%; 10/238), hos-
pital E in Uden (5.6%; 2/36) and hospital C in Tilburg 
(9.5%; 28/294).
In addition, seven of the nine hospitals (A in 
Roosendaal, B in Breda, C in Tilburg, D in ‘s-Hertogen-
bosch, E in Uden, F in Eindhoven and I in Nijmegen) 
had already tested HCW in the period from 27 February 
to 6 March 2020. They reported 10 positive HCW 
among 400 tested (2.5%). The percentage of positive 
HCW per hospital varied between 0% and 5.6% in this 
Figure 
Locations of the nine participating hospitals, with numbers of healthcare workers tested for SARS-CoV-2 and percentage of 
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respiratory syndrome coronavirus.
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period with the highest percentage in one hospital (D) 
in ‘s-Hertogenbosch.
In total, in the period from 27 February to 8 March 
2020, four of the nine hospitals had tested 786 patients 
with respiratory complaints, of whom 27 (3.4%) were 
positive. The percentage of positive patients varied 
between 1.1% (1/87) and 16.2% (16/99), with the high-
est percentage in hospital E.
Discussion
Since its first emergence in China in December 2019, 
SARS-CoV-2 has caused a pandemic affecting 134 
countries with a total of 142,539 COVID-19 cases 
including 5,393 deaths by 14 March 2020 [4]. Fatal out-
come was reported in the largest study from China to 
be 2,3% [5]. As at 15 March 2020, the Netherlands had 
officially registered 1,135 patients, with the majority 
of cases in the south-western part of the country [6]. 
Currently (15 March 2020), evidence is accumulating 
for unnoticed community transmission in the provinces 
Noord-Brabant and Limburg, with sporadic cases with 
unknown sources of infection elsewhere in the country. 
A 2-day rapid study among nine hospitals with HCW 
working and/or residing in an area of the Netherlands 
with suspected community transmission showed that 
4.1% of hospital staff with mild respiratory symptoms 
were infected with SARS-CoV-2. The observed geo-
graphic differences in positivity rates among HCW 
demonstrated focality of SARS-CoV-2 infection with 
foci in the region Breda–Tilburg and Uden. SARS-CoV-2 
infections among patients with respiratory complaints 
were primarily found in the hospital in Uden. Source 
and contact tracing was started by the regional public 
health service upon positive testing in the patients.
The results of the rapid assessment confirmed the 
suspicions at the OMT meeting on 6 March 2020 that 
unnoticed community transmission was ongoing in 
parts of Noord-Brabant. The results directly informed 
decisions on control measures at the national level (9 
March) and subsequently for additional regional meas-
ures (10 March). The study supported the implemented 
mitigation policy that was advised by the OMT on 6 
March in anticipation of the results of the assessment 
[7]. The additional measures undertaken by regional 
authorities involved requesting inhabitants of Noord-
Brabant to practice self-isolation at home when they 
developed a cough, symptoms of common cold and/or 
a fever. Furthermore, a ban of public events involving 
more than 1,000 people was implemented in this prov-
ince [8]. As the epidemiological situation developed, 
on 12 March 2020, self-isolation upon mild respiratory 
symptoms was implemented for the whole country, 
together with a ban of events with more than 100 peo-
ple [9]. Tailored advice was issued for people 70 years 
and older, persons belonging to medical risk groups 
and for persons involved with their care.
Here, we used SARS-CoV-2 infection rates among HCW 
with mild respiratory complaints without an epidemio-
logical link as a proxy for community transmission. As 
the study had to be conducted under enormous time 
constraints (started and completed within 2 days) to 
be able to rapidly inform urgent decision making, there 
was no opportunity to roll out a standardised study pro-
tocol. Nevertheless, data provided by the World Health 
Organization-China joint mission on COVID-19, support 
our approach. The mission report indicated that there 
were 2,055 laboratory-confirmed cases of COVID-19 
among HCW from 476 hospitals in China. Close inves-
tigation into these cases revealed that most of them 
could be traced back to exposure in households rather 
than in a healthcare setting [10].
We interpret the prevalence of 4% among HCW with 
mild respiratory illness and no epidemiological link 
as high and of concern. It suggests unnoticed commu-
nity transmission, with a potential risk of nosocomial 
transmission. Further evidence for ongoing community 
transmission was provided by the Nivel Primary Care 
Database sentinel surveillance for influenza-like illness 
(ILI) and other acute respiratory infections (ARI) [11]. 
While this is a small group of ca 40 practices covering 
0.8% of the Dutch population, eight ILI or ARI patients 
had tested positive by 14 March, one among 109 (0.9%) 
with a collection date in week 10 and nine among 125 
(7.23%) in week 11. The epidemiological situation in 
the Netherlands and elsewhere is developing rapidly, 
and additional measures involving further restrictions 
in the social life in the country are being prepared.
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